(6α,11β)-11,20-Dihydroxy-6-Methyl-3-oxopregna-1,4,17(20)-trien-21-al
|
|
- CAS-Nr.
- 1338549-02-2
- Englisch Name:
- (6α,11β)-11,20-Dihydroxy-6-Methyl-3-oxopregna-1,4,17(20)-trien-21-al
- Synonyma:
- Methylprednisolone EP IMP D;Methylprednisolone impurity 27;Methyl Prednisolone EP Impurity D;Methylprednisolone EP Impurity D2;Methylprednisolone Impurity D2(EP);Methylprednisolone EP Impurity D(EZ);Methylprednisolone Impurity 4(Methylprednisolone EP Impurity D);(E)-11β,20-dihydroxy-6α-methylpregna-1,4,17(20)- triene-3,21-dione;(EZ)-11β,20-dihydroxy-6α-methylpregna-1,4,17(20)-triene-3,21-dione;(Z)-11β,20-dihydroxy-6α-methylpregna-1,4,17(20)- triene-3,21-dione
- CBNumber:
- CB92653881
- Summenformel:
- C22H28O4
- Molgewicht:
- 356.46
- MOL-Datei:
- 1338549-02-2.mol
|
(6α,11β)-11,20-Dihydroxy-6-Methyl-3-oxopregna-1,4,17(20)-trien-21-al Eigenschaften
- Siedepunkt:
- 570.1±50.0 °C(Predicted)
- Dichte
- 1.24±0.1 g/cm3(Predicted)
- storage temp.
- Hygroscopic, -86°C Freezer, Under inert atmosphere
- L?slichkeit
- Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly)
- pka
- 9.44±0.70(Predicted)
- Aggregatzustand
- Solid
- Farbe
- White to Off-White
- Stabilit?t:
- Hygroscopic, Temperature Sensitive
Sicherheit
(6α,11β)-11,20-Dihydroxy-6-Methyl-3-oxopregna-1,4,17(20)-trien-21-al Chemische Eigenschaften,Einsatz,Produktion Methoden
Chemische Eigenschaften
Off-White Solid
(6α,11β)-11,20-Dihydroxy-6-Methyl-3-oxopregna-1,4,17(20)-trien-21-al Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
(6α,11β)-11,20-Dihydroxy-6-Methyl-3-oxopregna-1,4,17(20)-trien-21-al Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 55)Lieferanten
1338549-02-2()Verwandte Suche:
- (6α,11β)-11,20-Dihydroxy-6-Methyl-3-oxopregna-1,4,17(20)-trien-21-al
- Methylprednisolone Related IMpurity B1 (Methylprednisolone IMpurity D)
- Methyl Prednisolone EP Impurity D
- Methylprednisolone Impurity 4(Methylprednisolone EP Impurity D)
- Methylprednisolone Related Impurity B1 (Methylprednisolone Impurity D, Methylprednisolone Acetate EP Impurity D)
- Methylprednisolone EP IMP D
- Methylprednisolone Impurity D2(EP)
- Pregna-1,4,17(20)-trien-21-al, 11,20-dihydroxy-6-methyl-3-oxo-, (6α,11β)-
- Methylprednisolone EP Impurity D (Methylprednisolone Related Impurity B1)
- (EZ)-11β,20-dihydroxy-6α-methylpregna-1,4,17(20)-triene-3,21-dione
- (E)-11β,20-dihydroxy-6α-methylpregna-1,4,17(20)- triene-3,21-dione
- (Z)-11β,20-dihydroxy-6α-methylpregna-1,4,17(20)- triene-3,21-dione
- (6a,11β)-11,20-Dihydroxy-6-methyl-3-oxopregna-1,4,17(20)-trien-21-al
- Methylprednisolone EP Impurity D2(Methylprednisolone EP Impurity D)
- Methylprednisolone EP Impurity D2
- (6α,11β)-11,20-Dihydroxy-6-methyl-3-oxopregna-1,4,17(20)-trien-21-al
- Methylprednisolone impurity 27
- (6α,11β)-11,20-Dihydroxy-6-methyl-3-oxopregnα-1,4,17(20)-trien-21-al
- Methylprednisolone EP Impurity D(EZ)
- 1338549-02-2
- Impurities
- Intermediates & Fine Chemicals
- Pharmaceuticals
- Steroids
- Impurities, Pharmaceuticals, Intermediates & Fine Chemicals, Steroids